Alfonso Bermejo, M.D., Ph.D.

MINIFIV Clinical Director

MINIFIV Madrid

Información de contacto:
Social Media:
Alfonso Bermejo, M.D., Ph.D.

Biografía

Dr. Alfonso Bermejo, MD, is an attending physician at MINIFIV CLINIC Madrid, Spain, where he serves as the Clinical Director. He obtained his Medical degree from the University of Alcalá in 2005, and completed his residency training in Obstetrics and Gynecology at the La Paz Hospital in Madrid. In addition, Dr. Bermejo obtained his PhD at the Medicine and Surgery Department of the University of Rey Juan Carlos School of Health Sciences in 2013, and completed his Reproductive Endocrinology and Infertility fellowship training at IVI Madrid Clinic.

Dr. Bermejo has been involved in teaching since his early career, participating as lecturer for medical students of Rey Juan Carlos University.
Dr. Bermejo has been invited to speak nationally and internationally and has authored and co-authored many peer reviewed publications, and published book chapters. He serves as Ad Hoc Reviewer for Reproductive BioMedicine Online, Human Reproduction, and Reproductive Biology and Endocrinology. His research interests include minimal stimulation and natural IVF cycles and endometrial receptivity.

Read more

Formación

BS Claret Scholl (1999)
MD University of Alcalá (2005)
Ph.D. (Medicine) Rey Juan Carlos University (2013)
Residency La Paz Hospital (2010)
Fellowship IVI Madrid Clinic (2013)

Publicaciones


  • Protocolo de estimulación mínima basado en el citrato de clomifeno para tratamientos de FIV: resultados clínicos.
    Bermejo A, Aguilar JP, Seco L, Agüero R, Álvarez T, Navarro Y.
    Med Reprod, 2:55-61, 2015.

  • Mild ovarian stimulation using clomiphene citrate and menotropins versus clomiphene citrate and recombinant follicle-stimulating hormone/luteinizing hormone combination in low responder patients.
    Bermejo A, Ruiz F, Martínez-Salazar J, Mayoral M, García-Velasco JA.
    IVF Lite,1:36-40, 2014.

  • The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.
    Bermejo A, Iglesias C, Ruiz M, Blesa D, Simón C, Pellicer A, García-Velasco JA.
    Hum Reprod, 29:1271-8, 2014.

  • In vitro fertilization outcome in women with unoperated bilateral endometriomas.
    Benaglia L, Bermejo A, Somigliana E, Faulisi S, Ragni G, Fedele L, García-Velasco JA.
    Fertil Steril, 99:1714-9, 2013.

  • Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.
    Hauzman EE, Zapata A, Bermejo A, Iglesias C, Pellicer A, García-Velasco JA.
    Reprod Biol Endocrinol, 11(1):96, 2013.

  • Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.
    Bermejo A, Cerrillo M, Ruiz M, Blesa D, Simón C, Pellicer A, García-Velasco JA.
    Fertil Steril, 101:138-46, 2013.

  • Pregnancy outcome in women with endometriomas achieving pregnancy through IVF.
    Benaglia L, Bermejo A, Somigliana E, Scarduelli C, Ragni G, Fedele L, García-Velasco JA.
    Hum Reprod, 27:1663-7, 2012.

  • Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.
    García-Velasco JA, Bermejo A, Ruiz F, Martínez-Salazar J, Requena A, Pellicer A.
    Fertil Steril, 96:590-3, 2011.

  • Síndrome microcefalia-coriorretinopatía-linfedema.
    Novelle M, Bermejo A, Herrero B, Rodríguez R, González A.
    Prog Obstet Ginecol, 54(10):532-6, 2011.

Read more
Cerrar menú